National Geographic : 2005 Jul
SPECIAL ADVERTISING SECTION GlaxoSmithKline Helps Eliminate Elephantiasis by Stopping Transmission of the Disease A Global Health Problem Spread by mosquitoes, lymphatic filariasis (known as elephantiasis) is a painful, grotesquely disfiguring disease with no cure. It affects over 120 million people in 83 countries. This disabling disease causes tremendous physical suffering and economic deprivation within communities already gripped by poverty. Over one billion people are at risk-that's one in every six people on the planet. A Global Health Solution GlaxoSmithKline, in partnership with the World Health Organization (WHO), is helping to break the cycle of suffering over the next 20 years. To date, over 300 million albendazole treatments have been donated by GSK to help prevent new infections. Thirty million children are now protected and, one day, many more will have the chance to live free of lymphatic filariasis forever. good co rkpaes. GlaxoSmithKline Do more, feel better, live longer For additional information go to www.gsk.com/community or www.filariasis.org.